| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX5 ZNF410 HIVEP2 ZSCAN4 MYT1 ZNF521 SALL4 ZNF236 ZBTB24 TBX18 BPTF ZSCAN32 EEF1D SALL1 SNAPC4 MGA TET3 NPAS2 ZNF646 | 8.42e-06 | 1244 | 98 | 19 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX5 ZNF410 HIVEP2 ZSCAN4 MYT1 ZNF521 SALL4 ZNF236 ZBTB24 TBX18 BPTF ZSCAN32 EEF1D SALL1 SNAPC4 MGA TET3 NPAS2 ZNF646 | 1.14e-05 | 1271 | 98 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX5 ZNF410 HIVEP2 ZSCAN4 MYT1 ZNF521 SALL4 ZNF236 CIC ZBTB24 TBX18 BPTF ZSCAN32 EEF1D SALL1 SNAPC4 MGA TET3 NPAS2 ZNF646 | 2.29e-05 | 1459 | 98 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | phosphatase binding | 3.24e-04 | 264 | 98 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 5.94e-04 | 210 | 98 | 6 | GO:0019903 | |
| MousePheno | embryonic lethality during organogenesis | HBS1L AMBRA1 SALL4 F5 TGFBR2 BPTF SALL1 CEP120 TJP1 VCAN LRP1 ANKRD17 CABIN1 MAP2K5 AFF4 GAB1 | 2.54e-05 | 876 | 79 | 16 | MP:0006207 |
| MousePheno | absent triquetrum | 3.15e-05 | 2 | 79 | 2 | MP:0030862 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 4.33e-05 | 35 | 79 | 4 | MP:0031618 | |
| MousePheno | decreased muscle cell glucose uptake | 6.69e-05 | 39 | 79 | 4 | MP:0030022 | |
| MousePheno | abnormal triquetrum morphology | 9.43e-05 | 3 | 79 | 2 | MP:0030861 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.40e-04 | 47 | 79 | 4 | MP:0031617 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF804B ZNF646 | 6.11e-04 | 775 | 96 | 12 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF804B ZNF646 | 6.25e-04 | 777 | 96 | 12 | PS00028 |
| Domain | - | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF646 | 7.21e-04 | 679 | 96 | 11 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF804B ZNF646 | 7.72e-04 | 796 | 96 | 12 | IPR015880 |
| Domain | Znf_C2H2 | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF804B ZNF646 | 8.51e-04 | 805 | 96 | 12 | IPR007087 |
| Domain | zf-C2H2 | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF646 | 8.52e-04 | 693 | 96 | 11 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF646 | 8.62e-04 | 694 | 96 | 11 | IPR013087 |
| Domain | ZnF_C2H2 | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF804B ZNF646 | 8.79e-04 | 808 | 96 | 12 | SM00355 |
| Domain | PTB | 1.13e-03 | 40 | 96 | 3 | SM00462 | |
| Domain | PTB/PI_dom | 1.22e-03 | 41 | 96 | 3 | IPR006020 | |
| Domain | TF_T-box | 3.38e-03 | 17 | 96 | 2 | IPR001699 | |
| Domain | TBOX | 3.38e-03 | 17 | 96 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 3.38e-03 | 17 | 96 | 2 | IPR018186 | |
| Domain | - | 3.38e-03 | 17 | 96 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 3.38e-03 | 17 | 96 | 2 | PS50252 | |
| Domain | T-box | 3.38e-03 | 17 | 96 | 2 | PF00907 | |
| Domain | TBOX_1 | 3.38e-03 | 17 | 96 | 2 | PS01283 | |
| Domain | TBOX_2 | 3.38e-03 | 17 | 96 | 2 | PS01264 | |
| Domain | Pkinase_Tyr | 4.42e-03 | 129 | 96 | 4 | PF07714 | |
| Domain | SH3 | 5.15e-03 | 216 | 96 | 5 | SM00326 | |
| Domain | SH3 | 5.15e-03 | 216 | 96 | 5 | PS50002 | |
| Domain | SH3_domain | 5.56e-03 | 220 | 96 | 5 | IPR001452 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 5.61e-03 | 138 | 96 | 4 | IPR001245 | |
| Domain | Znf_C2H2_jaz | 5.65e-03 | 22 | 96 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 5.65e-03 | 22 | 96 | 2 | PF12171 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNB2 HIVEP2 MYO6 MYT1 SIPA1L3 INSR HECTD4 ZNF236 TASOR2 RLF ARFGEF3 ERGIC1 STK10 BPTF TBC1D4 TJP1 LRP1 ANKRD17 RPRD2 ANKRD12 TET3 AFF4 NPAS2 | 4.59e-11 | 1489 | 102 | 23 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP2 UBAP2 SIPA1L3 MBD1 SORBS1 CIC ARFGEF3 TBC1D4 ALMS1 TJP1 RABGAP1L ANKRD17 PLEKHA5 CLINT1 MAP3K21 ARHGAP21 GAB1 PPP1R12C | 6.61e-11 | 861 | 102 | 18 | 36931259 |
| Pubmed | SOX5 ZNF410 MYT1 MBD1 SALL4 KDM5D ZNF236 CIC ZBTB24 BPTF SALL1 ACIN1 SNAPC4 MGA NPAS2 ZNF646 | 1.84e-09 | 808 | 102 | 16 | 20412781 | |
| Pubmed | HIVEP2 MYO6 NUP98 SORBS1 CIC ANKRD17 PLEKHA5 MAP3K21 MGA MAP2K5 TNS1 HCK GAB1 | 2.00e-09 | 486 | 102 | 13 | 20936779 | |
| Pubmed | HBS1L CACNB2 DLGAP5 SALL4 TACC2 ATXN1L ZBTB24 SCML2 VCAN ACIN1 ANKRD17 CRYBG1 ANKRD12 MGA TNS1 FUBP3 ARHGAP21 AFF4 | 2.57e-09 | 1084 | 102 | 18 | 11544199 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UBAP2 SFSWAP DLGAP5 NUP98 CIC TASOR2 BPTF EEF1D SCML2 SALL1 TJP1 ACIN1 RPRD2 CLINT1 MGA FUBP3 AFF4 | 2.64e-09 | 954 | 102 | 17 | 36373674 |
| Pubmed | RBBP8 ZSCAN4 CIC RLF TBC1D4 SALL1 ALMS1 LRP1 ANKRD17 PLEKHA5 MGA ARHGAP21 | 3.96e-09 | 418 | 102 | 12 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 HIVEP2 ZSCAN4 NUP98 ZNF521 ATXN1L RLF BPTF SALL1 ALMS1 MGA | 7.44e-09 | 351 | 102 | 11 | 38297188 |
| Pubmed | CACNB2 UBAP2 CENPE SIPA1L3 DLGAP5 HECTD4 SORBS1 TJP1 LRP1 ANKRD17 PLEKHA5 CABIN1 MGA TNS1 ARHGAP21 AFF4 | 2.16e-08 | 963 | 102 | 16 | 28671696 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | UBAP2 SPATA31E1 NUP98 KDM5D CIC TASOR2 STK10 SALL1 CLINT1 MGA GAB1 | 5.91e-08 | 430 | 102 | 11 | 35044719 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | UBAP2 MYO6 DLGAP5 NUP98 TACC2 CIC SCML2 ALMS1 TJP1 ACIN1 ANKRD17 RPRD2 CLINT1 ARHGAP21 AFF4 | 9.67e-08 | 934 | 102 | 15 | 33916271 |
| Pubmed | BRIX1 SOX5 UBAP2 MYO6 NUP98 ZNF521 ATXN1L CIC RLF BPTF EEF1D SALL1 ALMS1 ANKRD17 RPRD2 CABIN1 MGA FUBP3 | 1.71e-07 | 1429 | 102 | 18 | 35140242 | |
| Pubmed | 2.01e-07 | 209 | 102 | 8 | 36779422 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF410 HIVEP2 ZSCAN4 MBD1 SALL4 KDM5D ZNF236 CIC ZBTB24 TBX18 ZSCAN32 SNAPC4 FUBP3 NPAS2 | 2.89e-07 | 877 | 102 | 14 | 20211142 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | DLGAP5 NUP98 SALL4 KDM5D TASOR2 BPTF EEF1D SCML2 SALL1 CEP120 | 3.86e-07 | 411 | 102 | 10 | 35182466 |
| Pubmed | HBS1L UBAP2 BPTF SCML2 ALMS1 TJP1 ACIN1 PLEKHA5 RPRD2 CLINT1 MGA | 6.70e-07 | 549 | 102 | 11 | 38280479 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | UBAP2 MYO6 SIPA1L3 SORBS1 EEF1D TJP1 CRYBG1 PLEKHA5 CLINT1 ARHGAP21 GAB1 | 8.87e-07 | 565 | 102 | 11 | 25468996 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.33e-07 | 256 | 102 | 8 | 33397691 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.25e-06 | 184 | 102 | 7 | 32908313 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.30e-06 | 363 | 102 | 9 | 14691545 | |
| Pubmed | BRIX1 SMPD4 CIC STK10 BPTF SCML2 PLEKHA5 RPRD2 FUBP3 ARHGAP21 | 1.35e-06 | 472 | 102 | 10 | 38943005 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MBD1 NUP98 SMPD4 CIC BPTF EEF1D TBC1D4 SALL1 LRP1 ANKRD17 CABIN1 MGA FUBP3 | 1.40e-06 | 857 | 102 | 13 | 25609649 |
| Pubmed | UBAP2 CENPE DLGAP5 SYTL2 SMPD4 GGT7 SCML2 ALMS1 TJP1 PLEKHA5 RPRD2 MGA | 1.68e-06 | 733 | 102 | 12 | 34672954 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SFSWAP RBBP8 DLGAP5 NUP98 CIC STK10 BPTF SCML2 TBC1D4 ACIN1 ANKRD17 SNAPC4 | 2.94e-06 | 774 | 102 | 12 | 15302935 |
| Pubmed | Genome-wide meta-analysis identifies new susceptibility loci for migraine. | 3.50e-06 | 78 | 102 | 5 | 23793025 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 7.48e-06 | 91 | 102 | 5 | 20362542 | |
| Pubmed | Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. | 8.52e-06 | 2 | 102 | 2 | 19476507 | |
| Pubmed | Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer. | 8.52e-06 | 2 | 102 | 2 | 30093628 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12395297 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19350679 | ||
| Pubmed | ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition. | 8.52e-06 | 2 | 102 | 2 | 28178529 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17295837 | ||
| Pubmed | 8.71e-06 | 14 | 102 | 3 | 16103213 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CENPE RBBP8 TACC2 SORBS1 CIC ARFGEF3 TBC1D4 SALL1 ALMS1 GAB1 | 9.35e-06 | 588 | 102 | 10 | 38580884 |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 9.96e-06 | 353 | 102 | 8 | 27545878 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.17e-05 | 361 | 102 | 8 | 26167880 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.25e-05 | 608 | 102 | 10 | 36089195 | |
| Pubmed | 1.31e-05 | 263 | 102 | 7 | 34702444 | ||
| Pubmed | 1.44e-05 | 104 | 102 | 5 | 9205841 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX5 ZNF410 HIVEP2 MYT1 ZNF236 CIC ZBTB24 TBX18 SALL1 SNAPC4 MGA NPAS2 | 1.46e-05 | 908 | 102 | 12 | 19274049 |
| Pubmed | Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities. | 1.62e-05 | 17 | 102 | 3 | 19168674 | |
| Pubmed | SFSWAP MYO6 INSR NUP98 TASOR2 ARFGEF3 TJP1 CLINT1 MGA ARHGAP21 GAB1 | 1.82e-05 | 777 | 102 | 11 | 35844135 | |
| Pubmed | SFSWAP TMEM165 MBD1 BTBD18 AMBRA1 BPTF ALMS1 LRP1 ANKRD17 MGA AFF4 ZNF646 WDR72 | 2.38e-05 | 1116 | 102 | 13 | 31753913 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BRIX1 SFSWAP MBD1 DLGAP5 NUP98 CIC BPTF SCML2 ACIN1 RPRD2 CABIN1 MGA FUBP3 TET3 | 2.55e-05 | 1294 | 102 | 14 | 30804502 |
| Pubmed | NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation. | 2.55e-05 | 3 | 102 | 2 | 38940430 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19440552 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 15010462 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17155964 | ||
| Pubmed | TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L. | 2.55e-05 | 3 | 102 | 2 | 33115448 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19815552 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20602916 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10978177 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 27471257 | ||
| Pubmed | Postnatal DNA demethylation and its role in tissue maturation. | 2.55e-05 | 3 | 102 | 2 | 29795194 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20628574 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 2852162 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 15777793 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23825698 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11374898 | ||
| Pubmed | Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes. | 2.55e-05 | 3 | 102 | 2 | 25800007 | |
| Pubmed | UBAP2 DLGAP5 HECTD4 AMBRA1 SMPD4 ANKRD17 PLEKHA5 RPRD2 ZNF646 | 2.66e-05 | 529 | 102 | 9 | 14621295 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.71e-05 | 552 | 102 | 9 | 10737800 | |
| Pubmed | 4.16e-05 | 23 | 102 | 3 | 20159597 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HBS1L CENPE TMEM165 SIPA1L3 SORBS1 CEP120 ALMS1 TJP1 CLINT1 MGA ARHGAP21 | 4.25e-05 | 853 | 102 | 11 | 28718761 |
| Pubmed | 4.28e-05 | 215 | 102 | 6 | 35973513 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.79e-05 | 440 | 102 | 8 | 34244565 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 5.04e-05 | 135 | 102 | 5 | 31077711 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 24942165 | ||
| Pubmed | CAP defines a second signalling pathway required for insulin-stimulated glucose transport. | 5.09e-05 | 4 | 102 | 2 | 11001060 | |
| Pubmed | Regulation and function of Spalt proteins during animal development. | 5.09e-05 | 4 | 102 | 2 | 19247946 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23518924 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 22761906 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26231217 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 15031295 | ||
| Pubmed | Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies. | 5.09e-05 | 4 | 102 | 2 | 35143327 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 29401624 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 16545361 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12504111 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9658397 | ||
| Pubmed | The H3.3 chaperone Hira complex orchestrates oocyte developmental competence. | 5.09e-05 | 4 | 102 | 2 | 35112132 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 5.10e-05 | 444 | 102 | 8 | 34795231 | |
| Pubmed | 5.11e-05 | 222 | 102 | 6 | 37071664 | ||
| Pubmed | 5.26e-05 | 446 | 102 | 8 | 24255178 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 5.65e-05 | 583 | 102 | 9 | 29844126 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | BRIX1 MYO6 SIPA1L3 NUP98 F5 TASOR2 EEF1D TJP1 ACIN1 ANKRD17 CRYBG1 PLEKHA5 CLINT1 | 8.00e-05 | 1257 | 102 | 13 | 36526897 |
| Pubmed | Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis. | 8.47e-05 | 5 | 102 | 2 | 32878998 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 30576429 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 32629174 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 18591668 | ||
| Pubmed | A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. | 8.47e-05 | 5 | 102 | 2 | 9447983 | |
| Pubmed | Sall1 is a transcriptional regulator defining microglia identity and function. | 8.47e-05 | 5 | 102 | 2 | 27776109 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 29526553 | ||
| Pubmed | HIVEP2 MYO6 SIPA1L3 MBD1 HECTD4 ZNF521 SORBS1 TXNDC11 TJP1 LRP1 CABIN1 ARHGAP21 AFF4 | 9.97e-05 | 1285 | 102 | 13 | 35914814 | |
| Pubmed | 1.21e-04 | 503 | 102 | 8 | 16964243 | ||
| Pubmed | Sall1, sall2, and sall4 are required for neural tube closure in mice. | 1.27e-04 | 6 | 102 | 2 | 18818376 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 11997497 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.38e-04 | 167 | 102 | 5 | 20362541 | |
| Pubmed | 1.44e-04 | 268 | 102 | 6 | 33640491 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.53e-04 | 271 | 102 | 6 | 32433965 | |
| Pubmed | Sall1 plays pivotal roles for lens fiber cell differentiation in mouse. | 1.77e-04 | 7 | 102 | 2 | 30929925 | |
| Interaction | YWHAH interactions | HIVEP2 UBAP2 SFSWAP SIPA1L3 HECTD4 SORBS1 ATXN1L CIC PYHIN1 ARFGEF3 TBC1D4 ALMS1 TJP1 RABGAP1L ANKRD17 PLEKHA5 CLINT1 GREM1 MAP3K21 ARHGAP21 GAB1 PPP1R12C | 1.40e-08 | 1102 | 99 | 22 | int:YWHAH |
| Interaction | YWHAG interactions | HIVEP2 UBAP2 SIPA1L3 MBD1 HECTD4 SORBS1 CIC PYHIN1 TBC1D4 ALMS1 TJP1 RABGAP1L ACIN1 ANKRD17 PLEKHA5 CLINT1 MAP3K21 ARHGAP21 GAB1 PPP1R12C | 2.31e-06 | 1248 | 99 | 20 | int:YWHAG |
| Interaction | HOXA4 interactions | 3.08e-06 | 21 | 99 | 4 | int:HOXA4 | |
| Interaction | RCOR1 interactions | SOX5 RBBP8 MYT1 CIC RLF SALL1 ALMS1 RABGAP1L ANKRD17 PLEKHA5 MGA ARHGAP21 | 5.51e-06 | 494 | 99 | 12 | int:RCOR1 |
| Interaction | SMC5 interactions | UBAP2 SFSWAP DLGAP5 NUP98 CIC TASOR2 BPTF EEF1D SCML2 SALL1 TJP1 ACIN1 RPRD2 CLINT1 MGA FUBP3 AFF4 | 6.91e-06 | 1000 | 99 | 17 | int:SMC5 |
| Interaction | SFN interactions | SIPA1L3 INSR SORBS1 TBC1D4 ALMS1 TJP1 RABGAP1L ANKRD17 PLEKHA5 MAP3K21 MAP2K5 ARHGAP21 GAB1 PPP1R12C | 7.12e-06 | 692 | 99 | 14 | int:SFN |
| Interaction | PHF21A interactions | RBBP8 CIC RLF TBC1D4 SALL1 ALMS1 RABGAP1L PLEKHA5 MGA ARHGAP21 | 7.29e-06 | 343 | 99 | 10 | int:PHF21A |
| Interaction | PYHIN1 interactions | BRIX1 MBD1 PYHIN1 VCAN ANKRD17 CRYBG1 CABIN1 MGA FUBP3 ZNF646 | 1.06e-05 | 358 | 99 | 10 | int:PYHIN1 |
| Interaction | PAX6 interactions | 1.28e-05 | 366 | 99 | 10 | int:PAX6 | |
| Interaction | NFIX interactions | 1.63e-05 | 227 | 99 | 8 | int:NFIX | |
| Interaction | TEAD1 interactions | 2.60e-05 | 176 | 99 | 7 | int:TEAD1 | |
| Interaction | WWTR1 interactions | HBS1L UBAP2 TGFBR2 BPTF SCML2 ALMS1 TJP1 PLEKHA5 RPRD2 CLINT1 | 4.32e-05 | 422 | 99 | 10 | int:WWTR1 |
| Interaction | FEV interactions | 6.46e-05 | 203 | 99 | 7 | int:FEV | |
| Interaction | FMR1 interactions | CACNB2 UBAP2 TACC2 TJP1 LRP1 ANKRD17 TNS1 FUBP3 ARHGAP21 AFF4 PPP1R12C | 6.48e-05 | 536 | 99 | 11 | int:FMR1 |
| Interaction | GJD3 interactions | MYO6 TMEM165 INSR SMPD4 GGT7 IFNGR1 TJP1 PLEKHA5 CLINT1 GAB1 | 7.94e-05 | 454 | 99 | 10 | int:GJD3 |
| Interaction | NAA40 interactions | UBAP2 MYO6 DLGAP5 NUP98 TACC2 CIC SCML2 ALMS1 TJP1 ACIN1 ANKRD17 RPRD2 CLINT1 ARHGAP21 AFF4 | 8.26e-05 | 978 | 99 | 15 | int:NAA40 |
| Interaction | HDAC1 interactions | RBBP8 MYT1 NUP98 ZNF521 SALL4 CIC RLF BPTF TBC1D4 SALL1 ALMS1 ANKRD17 PLEKHA5 CABIN1 MGA ARHGAP21 | 9.49e-05 | 1108 | 99 | 16 | int:HDAC1 |
| Interaction | GSK3A interactions | HBS1L SIPA1L3 ARFGEF3 TBC1D4 ALMS1 ACIN1 CRYBG1 PLEKHA5 ARHGAP21 GAB1 | 9.50e-05 | 464 | 99 | 10 | int:GSK3A |
| Interaction | TFCP2L1 interactions | 1.28e-04 | 99 | 99 | 5 | int:TFCP2L1 | |
| Interaction | ODF2 interactions | 1.30e-04 | 158 | 99 | 6 | int:ODF2 | |
| Interaction | CNOT9 interactions | 1.44e-04 | 231 | 99 | 7 | int:CNOT9 | |
| Interaction | KIF20A interactions | BRIX1 SFSWAP CENPE MYO6 MBD1 HECTD4 NUP98 AMBRA1 ALMS1 TJP1 RABGAP1L CLINT1 SNAPC4 TET3 PPP1R12C | 1.85e-04 | 1052 | 99 | 15 | int:KIF20A |
| Cytoband | 6q23.3 | 3.35e-05 | 28 | 102 | 3 | 6q23.3 | |
| Cytoband | 5p13.2 | 2.18e-03 | 31 | 102 | 2 | 5p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 2.42e-03 | 119 | 102 | 3 | chr6q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 2.54e-03 | 121 | 102 | 3 | chr6q21 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF410 HIVEP2 ZSCAN4 ZNF521 SALL4 ZNF236 ZBTB24 RLF ZSCAN32 SALL1 ZNF646 | 4.54e-05 | 718 | 65 | 11 | 28 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.69e-05 | 181 | 65 | 6 | 694 | |
| GeneFamily | Zinc fingers CXXC-type | 8.21e-04 | 12 | 65 | 2 | 136 | |
| GeneFamily | T-boxes | 1.88e-03 | 18 | 65 | 2 | 766 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.91e-03 | 26 | 65 | 2 | 904 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 196 | 101 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 169 | 101 | 6 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.96e-06 | 184 | 101 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.08e-06 | 185 | 101 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.76e-06 | 190 | 101 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.91e-06 | 191 | 101 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-06 | 195 | 101 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.21e-06 | 199 | 101 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.39e-06 | 200 | 101 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.68e-06 | 122 | 101 | 5 | a2f343962069253a08faa80fd70723b8488a99ec | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.58e-05 | 138 | 101 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-05 | 145 | 101 | 5 | bfa196ac1db7acbfcbb2ba9f137036a95e16e091 | |
| ToppCell | Myeloid-Myeloid-C_(Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 2.14e-05 | 147 | 101 | 5 | d7cfec8ec1b4854d783a1bb07b4f8d2b2fd22893 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.41e-05 | 162 | 101 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 166 | 101 | 5 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.83e-05 | 166 | 101 | 5 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.06e-05 | 168 | 101 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.06e-05 | 168 | 101 | 5 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-05 | 169 | 101 | 5 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 173 | 101 | 5 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 4.66e-05 | 173 | 101 | 5 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.19e-05 | 32 | 101 | 3 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.19e-05 | 32 | 101 | 3 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 178 | 101 | 5 | 829ea00c022a78d1861aa3ec53503272976775d9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Treg|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-05 | 178 | 101 | 5 | e37142a84d9713ff1571ce9f976842bf5c17c86f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 180 | 101 | 5 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 181 | 101 | 5 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.41e-05 | 185 | 101 | 5 | e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.41e-05 | 185 | 101 | 5 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.41e-05 | 185 | 101 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.57e-05 | 186 | 101 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.91e-05 | 188 | 101 | 5 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.91e-05 | 188 | 101 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 7.09e-05 | 189 | 101 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.09e-05 | 189 | 101 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 189 | 101 | 5 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 7.09e-05 | 189 | 101 | 5 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 189 | 101 | 5 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 190 | 101 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.27e-05 | 190 | 101 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.45e-05 | 191 | 101 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.45e-05 | 191 | 101 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 192 | 101 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 192 | 101 | 5 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-05 | 192 | 101 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.82e-05 | 193 | 101 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-05 | 193 | 101 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-05 | 193 | 101 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 194 | 101 | 5 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 194 | 101 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 194 | 101 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 8.02e-05 | 194 | 101 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 195 | 101 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 196 | 101 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 15-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 8.41e-05 | 196 | 101 | 5 | 511bfc06c34d5add2ae561cca463d1e4e2d43e20 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-05 | 196 | 101 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.41e-05 | 196 | 101 | 5 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-05 | 196 | 101 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 15-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 8.41e-05 | 196 | 101 | 5 | bf2670e5ae996a19987bc70aa5a37d133db789eb | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 8.62e-05 | 197 | 101 | 5 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-05 | 197 | 101 | 5 | 7c9df6025b9d168bd6d041c6cff1e87e08b11847 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.83e-05 | 198 | 101 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 198 | 101 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 8.83e-05 | 198 | 101 | 5 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.04e-05 | 199 | 101 | 5 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 9.04e-05 | 199 | 101 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 9.04e-05 | 199 | 101 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.25e-05 | 200 | 101 | 5 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.25e-05 | 200 | 101 | 5 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.25e-05 | 200 | 101 | 5 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.25e-05 | 200 | 101 | 5 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.25e-05 | 200 | 101 | 5 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-04 | 55 | 101 | 3 | 7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.67e-04 | 137 | 101 | 4 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.67e-04 | 137 | 101 | 4 | 2a5d2a99a2c532480d00b80a4885514a8a5c80fa | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.75e-04 | 138 | 101 | 4 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-04 | 145 | 101 | 4 | fd02d55755c35288a42ab08a82450b370aad35a7 | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.58e-04 | 148 | 101 | 4 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 3.77e-04 | 150 | 101 | 4 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 3.96e-04 | 152 | 101 | 4 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.06e-04 | 153 | 101 | 4 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.06e-04 | 153 | 101 | 4 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.06e-04 | 153 | 101 | 4 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 4.16e-04 | 154 | 101 | 4 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.16e-04 | 154 | 101 | 4 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.27e-04 | 155 | 101 | 4 | 7aba8ef53c9170ad8ed955c904c8991097ab1e32 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.27e-04 | 155 | 101 | 4 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-04 | 155 | 101 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-04 | 158 | 101 | 4 | ad1040bce6ad655c2502d9abb02507ecff177f83 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-04 | 158 | 101 | 4 | ac7aef01eda1dca80d6c5b508649fcad55803a67 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 160 | 101 | 4 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 8.89e-07 | 171 | 100 | 8 | 7535_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.61e-06 | 185 | 100 | 8 | 4755_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 1.53e-05 | 181 | 100 | 7 | 1791_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.59e-05 | 182 | 100 | 7 | 3630_DN | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.65e-05 | 183 | 100 | 7 | 7389_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.03e-05 | 189 | 100 | 7 | 5084_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; PC3; HG-U133A | 2.25e-05 | 192 | 100 | 7 | 452_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 2.40e-05 | 194 | 100 | 7 | 2009_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; PC3; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 5727_DN | |
| Disease | pain | 5.34e-05 | 196 | 99 | 6 | EFO_0003843 | |
| Disease | body weight | SOX5 CACNB2 HIVEP2 MBD1 INSR HECTD4 ZNF521 TXNDC11 PPP1R3A BPTF CEP120 RABGAP1L MGA MAP2K5 | 8.05e-05 | 1261 | 99 | 14 | EFO_0004338 |
| Disease | hematocrit | SOX5 HBS1L HIVEP2 UBAP2 INSR HECTD4 SORBS1 TBC1D4 SALL1 RABGAP1L ANKRD17 ARHGAP21 | 1.47e-04 | 1011 | 99 | 12 | EFO_0004348 |
| Disease | Autism Spectrum Disorders | 1.96e-04 | 85 | 99 | 4 | C1510586 | |
| Disease | uric acid measurement | 2.16e-04 | 610 | 99 | 9 | EFO_0004761 | |
| Disease | Acute Confusional Migraine | 3.95e-04 | 9 | 99 | 2 | C0521664 | |
| Disease | Status Migrainosus | 3.95e-04 | 9 | 99 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 3.95e-04 | 9 | 99 | 2 | C0270858 | |
| Disease | Sick Headaches | 3.95e-04 | 9 | 99 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 3.95e-04 | 9 | 99 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 3.95e-04 | 9 | 99 | 2 | C0018984 | |
| Disease | spleen volume | 4.10e-04 | 43 | 99 | 3 | EFO_0600047 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 4.40e-04 | 105 | 99 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 4.93e-04 | 10 | 99 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | HBS1L INSR HECTD4 LMBRD2 APLF ZBTB24 TXNDC11 STK10 SLC22A16 RABGAP1L CRYBG1 ANKRD12 ARHGAP21 | 5.67e-04 | 1347 | 99 | 13 | EFO_0005192 |
| Disease | coronary artery disease | HBS1L HIVEP2 TMEM165 HECTD4 GGT7 CEP120 LRP1 RPRD2 CABIN1 TNS1 ARHGAP21 WDR72 | 6.58e-04 | 1194 | 99 | 12 | EFO_0001645 |
| Disease | Polydactyly | 6.61e-04 | 117 | 99 | 4 | C0152427 | |
| Disease | creatinine measurement, glomerular filtration rate | 6.61e-04 | 117 | 99 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | carotid artery intima media thickness | 8.17e-04 | 450 | 99 | 7 | EFO_0007117 | |
| Disease | Migraine Disorders | 8.48e-04 | 13 | 99 | 2 | C0149931 | |
| Disease | acylcarnitine measurement | 8.98e-04 | 127 | 99 | 4 | EFO_0005059 | |
| Disease | alcohol consumption measurement | SOX5 TOPAZ1 ZNF521 ALMS1 KCNC2 RABGAP1L RPRD2 MGA MAP2K5 TET3 AFF4 NPAS2 | 9.26e-04 | 1242 | 99 | 12 | EFO_0007878 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 9.40e-04 | 57 | 99 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Anilide use measurement | 1.14e-03 | 15 | 99 | 2 | EFO_0009938 | |
| Disease | hepatoblastoma (is_marker_for) | 1.14e-03 | 15 | 99 | 2 | DOID:687 (is_marker_for) | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 1.22e-03 | 352 | 99 | 6 | EFO_0007014 | |
| Disease | opioid dependence | 1.24e-03 | 237 | 99 | 5 | EFO_0005611 | |
| Disease | colorectal mucinous adenocarcinoma | 1.30e-03 | 16 | 99 | 2 | EFO_0009361 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.30e-03 | 16 | 99 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.30e-03 | 16 | 99 | 2 | C2713443 | |
| Disease | carcinoma (implicated_via_orthology) | 1.32e-03 | 64 | 99 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | eosinophil count | HBS1L HIVEP2 RBBP8 MYT1 SIPA1L3 HECTD4 LMBRD2 TXNDC11 PPP1R3A BPTF TBC1D4 SALL1 TET3 | 1.41e-03 | 1488 | 99 | 13 | EFO_0004842 |
| Disease | Limb Deformities, Congenital | 1.47e-03 | 17 | 99 | 2 | C0206762 | |
| Disease | Adenomatous Polyposis Coli | 1.47e-03 | 17 | 99 | 2 | C0032580 | |
| Disease | reaction time measurement | 1.69e-03 | 658 | 99 | 8 | EFO_0008393 | |
| Disease | blood metabolite measurement | 1.84e-03 | 19 | 99 | 2 | EFO_0005664 | |
| Disease | age at first sexual intercourse measurement | 1.87e-03 | 383 | 99 | 6 | EFO_0009749 | |
| Disease | R-warfarin measurement | 2.03e-03 | 265 | 99 | 5 | EFO_0803324 | |
| Disease | breast carcinoma | 2.24e-03 | 1019 | 99 | 10 | EFO_0000305 | |
| Disease | cystatin C measurement | 2.38e-03 | 402 | 99 | 6 | EFO_0004617 | |
| Disease | Seckel syndrome | 2.46e-03 | 22 | 99 | 2 | C0265202 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 2.46e-03 | 22 | 99 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | goiter | 2.69e-03 | 23 | 99 | 2 | EFO_0004283 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.69e-03 | 23 | 99 | 2 | OBA_2045181 | |
| Disease | reticulocyte measurement | HBS1L UBAP2 INSR HECTD4 ATXN1L GGT7 SLC22A16 PCDHGB4 TNS1 ARHGAP21 | 2.84e-03 | 1053 | 99 | 10 | EFO_0010700 |
| Disease | vital capacity | HIVEP2 RBBP8 MYT1 ZBTB24 IFNGR1 TBX18 CEP120 RPRD2 SNAPC4 TNS1 GAB1 | 2.89e-03 | 1236 | 99 | 11 | EFO_0004312 |
| Disease | pallidum volume | 3.18e-03 | 25 | 99 | 2 | EFO_0006933 | |
| Disease | myeloproliferative disorder | 3.18e-03 | 25 | 99 | 2 | EFO_0004251 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSATQQEASGHPLKS | 121 | Q6ZRG5 | |
| LQKHSTPHAAFQPNS | 111 | Q9UKV3 | |
| ESSSNPSNPETLHAK | 346 | Q8IW19 | |
| LHSEQNKSSPDPTST | 2491 | P13611 | |
| VSKSSTHPQHNPNEN | 206 | Q99708 | |
| NNASSQKPTHSSCIP | 41 | Q8N888 | |
| HPETPKPSISSNNSN | 141 | P31997 | |
| ITNHSDQPPQNFSAT | 26 | Q9UPC5 | |
| IGPNDQKTPSQTAFH | 2031 | Q8TCU4 | |
| SNSPHGPSAKFLVQN | 131 | Q8TDN6 | |
| PEASDSQAAQKPQAH | 96 | Q8NC38 | |
| SHQPTPHSSENNSNL | 546 | Q9C0C7 | |
| DSTPNHPSQTTPAQK | 151 | Q6UB98 | |
| SSSAHSNQQQPPGSV | 2101 | O75179 | |
| TQSACQNSVHPANKP | 2226 | O75179 | |
| PSEAQPTHAQSSKPQ | 2436 | Q12830 | |
| PTHAQSSKPQVAAQS | 2441 | Q12830 | |
| EKSSPGHRATAPQTQ | 116 | P29692 | |
| VNPHKVSPASSVDSN | 481 | Q9UHB7 | |
| ANHRSPKPSANSVTS | 241 | Q08289 | |
| TASKSANPPHTIQAS | 211 | Q9Y450 | |
| ANPPHTIQASEEQSS | 216 | Q9Y450 | |
| NSSELTSHQQAPPNT | 791 | Q9UN71 | |
| HQREPNSDIPKNSST | 1076 | Q9UPP5 | |
| VFQNPDAHPANSSSA | 711 | Q99743 | |
| PESAGNKHSNSNSVD | 671 | P52948 | |
| NDPSASEHTQFKNIP | 411 | Q96PR1 | |
| DKASPDQNASTHTPQ | 296 | Q14677 | |
| PDKAQHNDSEQTQSP | 36 | O60565 | |
| HSSPENHNNAKEPDS | 1271 | Q8IWI9 | |
| TDCNDNVPSHKNPAS | 211 | Q13480 | |
| NVPSHKNPASSQSKH | 216 | Q13480 | |
| DQSDEAPKNPHCTSQ | 2886 | Q07954 | |
| HSFNKAPSATSPSGQ | 196 | P0C7T5 | |
| PSTDHSPFLKGNQNS | 1496 | Q9BY66 | |
| ATRTAQPDHTQAPTK | 426 | Q9UIS9 | |
| TANHSAPSLENSVQP | 521 | Q9UJ14 | |
| KVNTRAGPSQHSSPA | 121 | Q13163 | |
| NSPVCHSKFQNTTSP | 336 | A0A1B0GTH6 | |
| HVSTHSATAQPQNPD | 131 | Q969X5 | |
| KQSHAASAAPQASSP | 526 | Q96I24 | |
| PNVNALTHENQTKPS | 66 | Q8NC54 | |
| SPPFESEDSQKHNQS | 686 | P06213 | |
| ASQHLATESPDSPNK | 3771 | Q9Y4D8 | |
| NSLKPEQASPSAHSH | 381 | Q9NXE4 | |
| HSFGDIPASQTNKPS | 86 | Q5R372 | |
| TNRAPQNSSPFSKHH | 906 | Q16821 | |
| TPQEKNSSPSSHSQE | 216 | B2RXH4 | |
| NSSPSSHSQEPRENK | 221 | B2RXH4 | |
| TSTIKPGPNSHNSNT | 56 | P08631 | |
| QPKSSSTNPSQAKAH | 1011 | Q9BX69 | |
| AQRQASGDTPTTPKH | 1916 | Q9Y6J0 | |
| VPSHNQSPPTKDDAT | 386 | Q8N960 | |
| NSSSVFQPNPDNHSV | 301 | P57773 | |
| SPKTPNNFDHAQSCQ | 1676 | Q5TH69 | |
| QEQSQHPKPSEASTT | 416 | Q6K0P9 | |
| TSPENAGPQNTKSEH | 661 | Q15398 | |
| KPQHTFSDSQSPAES | 446 | Q9Y4K1 | |
| PSKNDSFFTPDSNHN | 931 | Q5VT52 | |
| PSNSTQEFHKSPSIE | 931 | Q9NSC2 | |
| QAKLPHANIPSATSS | 291 | Q9UJQ4 | |
| PTTQDNKNPHVTSRA | 2361 | Q02224 | |
| SHSSLSDSEFPPNNK | 421 | P15260 | |
| PFNSSKLPEGHSSQQ | 161 | Q9HCH5 | |
| NGQPSKPDTSDHQVS | 281 | Q8NC24 | |
| RKAQADSSTPTPHNA | 331 | Q12872 | |
| QSRGQEPQAPSSSKH | 326 | Q9BZL4 | |
| LAEPQKAPSHQQATT | 791 | P12259 | |
| KAPSHQQATTAGSPL | 796 | P12259 | |
| HAAANSSPPENSNIT | 66 | Q68DH5 | |
| PSDFQHKITVQASPN | 516 | Q5TCX8 | |
| QGPVSNSPTEVQKHN | 331 | Q86VW1 | |
| HSNPSPSQDTDGTKA | 96 | O60292 | |
| ASTIPPHVQKSVNND | 21 | P37173 | |
| PSSQNAHSVPLDKAS | 461 | Q6ZUB1 | |
| SEAQQPASHPVASNQ | 56 | Q96RK0 | |
| TTNTKEPQGLPDHNS | 221 | Q8IXR9 | |
| LQKPVPHSQASEANS | 296 | Q5T6F2 | |
| EPSEQKSTVHLNPNS | 391 | A4D1E1 | |
| HPSSNKDPTQGQKSA | 11 | Q9NX65 | |
| QPEEPTFKGSQSSHQ | 156 | Q9NX65 | |
| KSPSAIPEQNHSLND | 631 | Q13129 | |
| SAQAQAHTSAPTPAQ | 261 | A0A1B0GUW6 | |
| QNPSPSQDFGLHKNS | 736 | A0A1B0GUW6 | |
| STHQQSASASVPKNP | 1046 | Q9UBZ9 | |
| SPSEASQHSMQSPQK | 256 | Q9UQR0 | |
| QQQHKVSPASESPFS | 36 | Q9NX95 | |
| PSPSSNAFATNQTHQ | 501 | O95935 | |
| SHQQPESCNHSNSPS | 331 | Q96K83 | |
| PDDTTNHSNSSKEVP | 56 | Q86VK4 | |
| TLENHTQNSSEVSPP | 336 | O94804 | |
| SVHPNLPSDKSQDAT | 136 | Q9BX66 | |
| NKAPSANVPQSSAIS | 626 | Q9BX66 | |
| NQDFHSKSPASSSLP | 806 | Q9HBL0 | |
| PVSPVKHDSNSNSAN | 1051 | Q3MJ13 | |
| KPATGQPNSSSHSAN | 796 | O15015 | |
| SEKHLQPSQAQPETS | 826 | O95359 | |
| APVHTNKEDPATQTN | 76 | Q9HC07 | |
| APTPSSEPDTHQKAQ | 511 | O43151 | |
| SAPSHVQPSDSEKNR | 341 | O60343 | |
| SQPEQSSPESALTHQ | 276 | Q8NAM6 | |
| GSHEKKPSSNPNQDD | 451 | Q3C1V9 | |
| KPSSNPNQDDFHSSE | 456 | Q3C1V9 | |
| TDFQNNHSSPKPTTL | 126 | O43167 | |
| HHSDPASSPQNVANS | 796 | Q6PKC3 | |
| SEPAKPAHSQNQSNF | 1381 | Q07157 | |
| PSFTKQGNNSKPSNH | 771 | Q8N9V7 | |
| HAKTSAPHAQNPDVS | 416 | Q9UL36 | |
| FPNVPAQEASKSASH | 846 | Q5SXM2 | |
| FAPHNSSTSPQKAEE | 101 | P35711 | |
| QHSASSANVFPKESP | 1996 | Q5VWN6 | |
| FSPQDETQTANHKPE | 1036 | Q9HAU0 | |
| PNPSLNTKADDSHTV | 351 | P31629 | |
| AANAQPHKLSETPGS | 1936 | Q5T5U3 | |
| PQPSDQHFTSAVHQK | 536 | Q9UM54 | |
| SHEKQQPQTGDPSKS | 521 | Q01538 | |
| AAAEHGQKPQTPSAS | 141 | Q8NBZ9 |